Cell & Gene Therapy Manufacturing Services Market Size, Share, Revenue, Trends And Drivers For 2024-2033

January 25, 2024 01:30 AM AEDT | By EIN Presswire

Google News:

Cell & Gene Therapy Manufacturing Services Market Size, Share, Revenue, Trends And Drivers For 2024-2033 — Image source: EIN Presswire

Recent News

ASX 200 Edges Up as Santos Lifts Sentiment While ASX Ltd and Gold Mine...

ASX 200 Climbs as Ceasefire Comments Boost Market Confidence

Dexus (ASX:DXS) Boosts Property Valuations, Declares H2 Distribution A...

Virgin and Greatland Energise ASX 200 as Woodside Retreats

LONDON, GREATER LONDON, UK, January 24, 2024 /EINPresswire.com/ -- Business Research Company's Year-End Special: Get a 33% discount on Opportunities and Strategies Reports

The Business Research Company’s “Cell & Gene Therapy Manufacturing Services Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the cell & gene therapy manufacturing services market size is predicted to reach $15.77 billion in 2028 at a compound annual growth rate (CAGR) of 16.6%.

The growth in the cell & gene therapy manufacturing services market is due to the high incidence of cancer and other target diseases. North America region is expected to hold the largest cell & gene therapy manufacturing services market share. Major players in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec.

Cell & Gene Therapy Manufacturing Services Market Segments
• By Type: Gene Therapy, Cell Therapy
• By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
• By Application: Commercial Manufacturing, Clinical Manufacturing
• By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
• By Geography: The global cell & gene therapy manufacturing services market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10035&type=smp

Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.

Read More On The Cell & Gene Therapy Manufacturing Services Global Market Report At:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cell & Gene Therapy Manufacturing Services Market Characteristics
3. Cell & Gene Therapy Manufacturing Services Market Trends And Strategies
4. Cell & Gene Therapy Manufacturing Services Market – Macro Economic Scenario
5. Cell & Gene Therapy Manufacturing Services Market Size And Growth
……
27. Cell & Gene Therapy Manufacturing Services Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Cell & Gene Therapy Manufacturing Services Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Central Lab Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report

COVID-19 Rapid Test Kits Global Market Opportunities And Strategies To 2031
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

View All

Markets

Related Articles

Sponsored Articles

1

2

3

4

5

Investing Ideas

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27